Sustainability & Climate

Aligos Therapeutics is using strategic stock grants to lure top talent. Is this a savvy growth play or a creeping cost for shareholders? We break it down.

Serve Robotics just deployed the largest U.S. sidewalk delivery fleet. We dive into the tech, the competition, and the high-stakes economics of this silent revolution.

A hybrid law firm just won a top ABA award by building a tech platform to help disabled Americans navigate bureaucracy. Is this the future of legal access?

Long Beach's new Black-Serving Institution status isn't just an equity win; it's a strategic investment in the diverse STEM talent America's defense sector needs.

An independent study shows Mesoblast’s cell therapy has superior remission rates over a market leader, hinting at a new standard of care and a big win for investors.

With a $2.5B boost from Blue Owl, Finance of America aims to move beyond reverse mortgages and reshape how millions of retirees access their home equity.

As John Lindsay retires, H&P anoints tech-savvy insider Trey Adams. A look at how this smooth transition secures a legacy of innovation.

New journalism awards tackle AI's risks and Indigenous health gaps, revealing how media innovation aims to build a healthier, more equitable Canada.

Nusano won a "Best Company" award, but the real story is how its culture is a strategic asset powering its mission to disrupt the critical isotope market.

A top advisor's move to independence reveals a major shift in how ultra-high-net-worth families are securing multi-generational wealth and resilience.

First Trust unveils its new Dividend Aristocrats Target Income ETF in Europe, blending stable dividend stocks with a covered call strategy for yield-seekers.

A funding round reveals a deeper strategy to tackle the healthcare labor crisis and soaring Medicaid costs with tech, data, and a focus on human dignity.

An Atlanta initiative is scaling a proven model to close the 'word gap.' It's not just about equity; it's a long-term investment in our future economy.

Beyond logistics, new AI-powered systems are redefining trust and efficiency in drug development. See how one company is setting a new human-centered standard.

A major hedge fund's move in a $2.4B semiconductor deal reveals a critical truth: the future of precision medicine is built on high-speed data infrastructure.

Andersen Consulting partners with LBC, signaling a strategic shift to ethically-grounded AI. How will this human-first approach reshape global transformation?

After years of delays, River Rock Capital Partners has taken over a stalled NC project, betting on unmet demand in one of the state's fastest-growing areas.

Subsense just raised $27M for a BCI delivered via nasal spray. It could democratize neurotech, but what's the cost to our identity and safety?

A Florida health center's new pharmacy is more than a convenience. It's a look into a powerful model blending tech and finance to create sustainable care.

A $3.4M contract for a custom rig reveals a strategic shift in Canada's energy sector, where bespoke technology is the new competitive advantage.